Journal article

The Choice of Multiple Myeloma Induction Therapy Affects the Frequency and Severity of Oral Mucositis After Melphalan-Based Autologous Stem Cell Transplantation

Shaun Fleming, Simon J Harrison, Piers Blombery, Trish Joyce, Kerrie Stokes, John F Seymour, H Miles Prince, David Ritchie

Clinical Lymphoma Myeloma and Leukemia | CIG MEDIA GROUP, LP | Published : 2014

DOI: 10.1016/j.clml.2014.02.001

Citation metrics

8Web of Science
9Scopus

Keywords

Neoplasm Staging
Female
Aged
Consolidation
Hematology
Remission Induction
Oncology
Steroids
Transplantation Conditioning
Transplantation, Autologous
Male
Severity of Illness Index
Stomatitis
Anthracyclines
Mucositis
Humans
Bortezomib Plus Dexamethasone
Hematopoietic Stem Cell Transplantation
Multiple Myeloma
Autologus Transplantation
Melphalan
Adult
Thalidomide
High-Dose Chemotherapy
Risk-Factors
Novel Therapy
Life Sciences & Biomedicine
Antineoplastic Combined Chemotherapy Protocols
Middle Aged
Science & Technology
Myeloma
Supportive Care
Doxorubicin
Treatment Outcome
Malignancies
Lenalidomide
Vad
Induction Chemotherapy